Emcure Pharmaceuticals Share Price, Technical, Fundamental Analysis, Financials, Shareholding, RSI, MACD and Moving Averages
Price on NSE
Price on BSE
Emcure Pharmaceuticals (EMCURE (Bse Code: 544210)) Key Ratios
Emcure Pharmaceuticals Share Price Analysis API (Live)
Emcure Pharmaceuticals share price is ₹1,869.40, day high (share price) is ₹1,893.00, day low (share price) is ₹1,850.00 and volume is 133,174. 52 Week high share price for Emcure Pharmaceuticals is ₹2,048.00 on 10 Aug 2026 and 52 week low share price for Emcure Pharmaceuticals is ₹1,260.00 on 01 Oct 2025. Price data as of: 28 Aug, 2026 3:31 PM.
According to latest price data (as of 28 Aug, 2026 3:31 PM) for Emcure Pharmaceuticals share, 14 day period RSI (Relative Strength Index) is 45.6, 50 DMA (50 Displaced Moving Average) is 1,877.72 and 200 DMA (200 Displaced Moving Average) is 1,620.09.
Emcure Pharmaceuticals (EMCURE) Technical Analysis
Emcure Pharmaceuticals Technical Data and Analysis available in multiple timeframes.
Emcure Pharmaceuticals Oscillators Analysis
Emcure Pharmaceuticals Price Action
Emcure Pharmaceuticals Oscillators Overview
| Indicator | Value |
|---|---|
| RSI (14) | 45.55 |
| Stoch %K (14, 3, 3) | 19.04 |
| CCI (20) | -71.79 |
| ADX (14) | 20.26 |
| Awesome Osc | -38.67 |
| Momentum (10) | -62.90 |
| MACD (12, 26, 9) | -6.95 |
| MACD Signal | 5.02 |
| Stoch RSI (14) | 17.81 |
| Williams %R (14) | -79.83 |
| Bull/Bear Power | -31.71 |
| Ultimate Osc | 33.44 |
| MFI (14) | 45.29 |
| ROC (21) | -2.17 |
| ROC (125) | 30.32 |
| ATR (14) | 50.07 |
Emcure Pharmaceuticals Moving Averages
| Ichimoku Base | 1,939.05 | Below Base |
| VWMA (20) | 1,925.98 | Below VWMA |
| HMA (9) | 1,863.94 | Above HMA |
Emcure Pharmaceuticals Technical SWOT Analysis
STRENGTHS
- Price is trading above the 200 DMA, indicating relatively stronger long-term positioning.
WEAKNESSES
- Price is below the 50 DMA, suggesting weaker medium-term positioning.
- MACD is below the signal line and in negative territory, reflecting downward momentum.
OPPORTUNITIES
- No specific opportunity signals are identified; the setup appears neutral.
THREATS
- No immediate technical risk signals are identified.
Emcure Pharmaceuticals Daily Pivot Points (Support & Resistance)
| Level | Classic | Woodie's | Camarilla | Fibonacci |
|---|---|---|---|---|
| Resistance 3 | 1,934.60 | 1,943.40 | 1,881.23 | 1,913.80 |
| Resistance 2 | 1,913.80 | 1,918.20 | 1,877.28 | 1,897.37 |
| Resistance 1 | 1,891.60 | 1,900.40 | 1,873.34 | 1,887.23 |
| Pivot Point | 1,870.80 | 1,875.20 | 1,869.40 | 1,870.80 |
| Support 1 | 1,848.60 | 1,857.40 | 1,865.46 | 1,854.37 |
| Support 2 | 1,827.80 | 1,832.20 | 1,861.52 | 1,844.23 |
| Support 3 | 1,805.60 | 1,814.40 | 1,857.58 | 1,827.80 |
| Date | Close | ADX | PDI | MDI | Aroon Up | Aroon Down | Bollinger UB | Bollinger MB | Bollinger LB | CCI | CMF | MACD | Signal | MFI | PSAR | RSI (F) | RSI | Sto (F) %K | %D | Supertrend | Ult Osc | Wil %R |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synchronizing oscillators history... | ||||||||||||||||||||||
| Date | Close | SMA(5) | EMA(5) | SMA(8) | EMA(8) | SMA(9) | EMA(9) | SMA(10) | EMA(10) | SMA(12) | EMA(12) | SMA(20) | EMA(20) | SMA(21) | EMA(21) | SMA(26) | EMA(26) | SMA(30) | EMA(30) | SMA(34) | EMA(34) | SMA(50) | EMA(50) | SMA(100) | EMA(100) | SMA(150) | EMA(150) | SMA(200) | EMA(200) | Ichimoku Base | VWMA(20) | HMA(9) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synchronizing moving averages history... | ||||||||||||||||||||||||||||||||
Emcure Pharmaceuticals - Shareholding Pattern
Historical breakdown of ownership percentages over time.
| Category | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Promoters | 77.83% | 77.87% | 77.87% | 77.88% |
| FII | 4.88% | 3.35% | 3.59% | 3.29% |
| DII (Other) | 1.60% | 1.16% | 1.27% | 0.79% |
| Retail & Others | 8.83% | 12.68% | 12.44% | 14.46% |
| Mutual Funds | 6.87% | 4.94% | 4.83% | 3.58% |
Emcure Pharmaceuticals - Yearly Income Statement (in ₹ Crore)
| Period | Revenue | Operating Profit | Net Profit |
|---|---|---|---|
| Mar 2026 | 9,216.20 +15.73% | 1,287.14 +32.51% | 941.27 +33.05% |
| Mar 2025 | 7,963.26 +18.58% | 971.35 +33.57% | 707.47 +34.1% |
| Mar 2024 | 6,715.24 +11.33% | 727.23 -2.68% | 527.58 -6.1% |
| Mar 2023 | 6,031.72 | 747.22 | 561.85 |
Emcure Pharmaceuticals - Corporate Actions
| Type | Ex-Date | Amount / Ratio | Details |
|---|---|---|---|
| Dividend | 14 Aug 2025 | ₹3 | View Details |
|
Announcement date
22 May 2025
Ex dividend date
14 Aug 2025
Record date
14 Aug 2025
Dividend type
Final
Amount
3.0
Dividend %
30.0
Details
Rs.3.0000 per share(30%)Final Dividend
|
|||
